Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Main inclusion criteria:

Diagnosis of small cell lung cancer.
Patients must have had one prior chemotherapy regimen which must have included either cisplatin or carboplatin.

[Additional eligibility criteria apply.]

Exclusion Criteria:

Prior radiotherapy that included > 30% of the bone marrow (i.e., the whole of the pelvis or half of the spine).
Significant chronic or recent acute gastrointestinal disorder with diarrhea as a major symptom.
Significant heart disease.
Uncontrolled, untreated, unstable, or symptomatic brain tumors or central nervous system disease.
Grade 2+ peripheral neuropathy (a condition caused by damage to the nerves in the peripheral nervous system).

[Additional exclusion criteria apply.]